Cases & Deals

BioMarin establishes global patent portfolio for PAL technology

Clients BioMarin Pharmaceutical, Inc.

On behalf of BioMarin Pharmaceutical, Inc., Jones Day assisted with global patent portfolio development and prosecution strategies regarding Prokaryotic Phenylalanine Ammonia-Lyase (PAL).

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.